Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 89,032 Enhabit, Inc. $EHAB

Connor Clark & Lunn Investment Management Ltd. purchased a new position in Enhabit, Inc. (NYSE:EHAB) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 89,032 shares of the company’s stock, valued at approximately $858,000.

A number of other institutional investors have also recently made changes to their positions in the company. Jones Financial Companies Lllp increased its holdings in shares of Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after purchasing an additional 8,879 shares during the last quarter. Strs Ohio purchased a new position in Enhabit during the 1st quarter valued at approximately $82,000. CWM LLC grew its holdings in Enhabit by 383.6% during the 1st quarter. CWM LLC now owns 11,738 shares of the company’s stock valued at $103,000 after buying an additional 9,311 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Enhabit in the 1st quarter worth approximately $114,000. Finally, Mackenzie Financial Corp raised its holdings in shares of Enhabit by 12.1% during the 1st quarter. Mackenzie Financial Corp now owns 14,468 shares of the company’s stock worth $127,000 after acquiring an additional 1,564 shares in the last quarter.

Enhabit Price Performance

Shares of Enhabit stock opened at $8.04 on Wednesday. The stock has a market cap of $406.65 million, a price-to-earnings ratio of -32.14 and a beta of 1.69. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. The stock has a 50 day moving average price of $8.11 and a 200-day moving average price of $8.39. Enhabit, Inc. has a one year low of $6.47 and a one year high of $10.90.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.05. The company had revenue of $263.60 million for the quarter, compared to analyst estimates of $267.08 million. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Equities analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on EHAB. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a report on Thursday, November 13th. UBS Group decreased their price target on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Enhabit presently has an average rating of “Hold” and a consensus target price of $9.00.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.